GlassScriptPhysician profile
K John Heilman
NPI 1659344430
$4,516.96
in general payments reported to CMS, 2019-2025
23 companies · $1,274 in 2025
The $1,274 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $255 · 2021: $315 · 2022: $134 · 2023: $90.67 · 2024: $1,864 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,606 · Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,605.74 |
| Food and Beverage | $622.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,821.47 | 2022-2024 | Aveir |
| Boston Scientific Corporation | $1,468.04 | 2019-2025 | Ingevity+, Emblem Mri S-Icd |
| Janssen Pharmaceuticals, INC | $180.10 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $175.72 | 2019 | |
| Medtronic, INC. | $137.93 | 2021-2023 | In.Pact Av |
| Heartflow, INC. | $130.90 | 2025 | |
| United Therapeutics Corporation | $111.60 | 2019-2020 | |
| Biotronik INC. | $88.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $67.84 | 2019-2021 | |
| Amgen INC. | $58.17 | 2019-2020 | |
| Medtronic Vascular, INC. | $51.81 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $46.08 | 2019-2020 | |
| Chiesi USA, INC. | $37.63 | 2019 | |
| Pfizer INC. | $34.30 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $33.95 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $22.78 | 2023 | Impella |
| Sanofi-Aventis U.S. LLC | $13.45 | 2019 | |
| Amarin Pharma, INC. | $12.61 | 2020 | |
| Teleflex LLC | $12.59 | 2019 | |
| Medtronic USA, INC. | $11.06 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw K Heilman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.